Katharina G. McFarland, Director at Transphorm, Inc. (TGAN), sold 3,996 shares at $4.81 ($19K) on 2024-02-28, disclosed to the SEC on 2024-03-01.
Scheduled sale ($19k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| TGAN | SELL | 2024-05-24 | $20K | — | Filing → |
| TGAN | SELL | 2024-04-26 | $4K | — | Filing → |
| SAIC | SELL | 2024-04-12 | $191K | — | Filing → |